FDA recall D-1040-2017
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · Class II · drug
Product
Testosterone Cypionate + Progesterone, 200 mg/ 2.5 mg/mL ,10 mL amber glass vials, Rx Only, Compounded by AXIA Pharmaceutical, Los Angeles, CA 90025
Reason for recall
CGMP Deviations
Distribution
There were only one customer in California
Key facts
- Status
- Terminated
- Initiation date
- 2017-07-12
- Report date
- 2017-08-09
- Termination date
- 2019-01-14
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Los Angeles, CA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1040-2017